180 WEALTH ADVISORS, LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1730817
FEDERAL WAY, WA
Position in RXRX
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$699,362
+$178,439 QoQ
Shares Held
190,562
+12.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#3
of 58 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $26,828,326 across 11 Biotechnology names. RXRX ranks #4 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MNKD |
Mannkind Corp
|
4,959,351 | $21,126,835 | |
| 2 | MRNA |
Moderna, Inc.
|
35,750 | $2,503,572 | |
| 3 | INCY |
Incyte Corp
|
7,045 | $798,621 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
190,562 | $699,362 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,257 | $395,796 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
8,753 | $341,454 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
548 | $272,208 | |
| 8 | EXEL |
Exelixis, Inc.
|
4,266 | $232,113 |
All Filings in RXRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $699,362 | 190,562 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $520,923 | 169,682 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $381,192 | 93,201 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $274,402 | 56,230 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $199,515 | 39,430 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $152,166 | 28,765 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $211,114 | 31,230 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $169,857 | 25,775 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $130,912 | 17,455 | Shares | Sole | 2024-07-16 | |
| No filing history on record for this holder in this stock. | ||||||